Chemical approaches to the study of protein tyrosine kinases and their implications for mechanism and inhibitor design

被引:18
|
作者
Cole, PA [1 ]
Sondhi, D [1 ]
Kim, K [1 ]
机构
[1] Rockefeller Univ, Bioorgan Chem Lab, New York, NY 10021 USA
关键词
protein kinases; transition state; mechanism; inhibition; selectivity; expressed protein ligation;
D O I
10.1016/S0163-7258(98)00046-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Protein tyrosine kinases are critical enzymes for signal transduction. Using C-terminal Src kinase (Csk) as a model system, we discuss progress in three main areas, First, we describe our efforts to measure the transition state of the reaction using peptide substrates containing fluorotyrosine analogs. It is shown that the Br phi nsted nucleophile coefficient for the reaction is near zero (similar to the nonenzymatic reaction) and the required nucleophile is the neutral phenol (rather than the more chemically reactive phenoxide anion). By studying the kinase reaction in the reverse direction, a Br phi nsted leaving group coefficient of -0.3 was measured, indicative of protonation of the departing phenol in the transition state. Taken together, these results strongly support a dissociative transition state mechanism for the kinase. These findings set constraints on the design of transition state analog inhibitors Second, we describe efforts toward defining the specificity of Csk for peptide and protein substrates. The main findings are that local amino acids surrounding a phosphorylated tyrosine can influence recognition, but that long-range interactions probably are more important in a physiologic protein substrate. These findings underscore the complexities in how protein kinases select protein substrates. Third, we describe a new method in protein engineering that has been applied to the study of protein kinases. The method, expressed protein ligation, allows a general approach for ligating synthetic peptides to recombinant proteins. Using expressed protein ligation, obtaining site-specifically phosphorylated proteins and proteins with the incorporation of biophysical probes becomes relatively straightforward. We have used this method to generate a tail phosphorylated, conformationally altered Csk that showed an unexpected increase in kinase activity. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 6 条
  • [1] Tyrosine kinase inhibitor–induced hypothyroidism: mechanism and clinical implications
    Zhipeng Wang
    Hongsen Wang
    Chen Bu
    Bosu Meng
    Yuhui Mu
    Shouhong Gao
    Wansheng Chen
    Xia Tao
    European Journal of Clinical Pharmacology, 2024, 80 : 827 - 838
  • [2] Tyrosine kinase inhibitor-induced hypothyroidism: mechanism and clinical implications
    Wang, Zhipeng
    Wang, Hongsen
    Bu, Chen
    Meng, Bosu
    Mu, Yuhui
    Gao, Shouhong
    Chen, Wansheng
    Tao, Xia
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (06) : 827 - 838
  • [3] Intrinsic relative preference profile of pan-kinase inhibitor drug staurosporine towards the clinically occurring gatekeeper mutations in Protein Tyrosine Kinases
    Ren, Zheng
    Li, Qian
    Shen, Yiwen
    Meng, Ling
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2021, 94
  • [4] Protein Alpha Shape Similarity Analysis (PASSA): A new method for mapping protein binding sites. Application in the design of a selective inhibitor of Tyrosine kinase 2
    Kristin Tøndel
    Endre Anderssen
    Finn Drabløs
    Journal of Computer-Aided Molecular Design, 2002, 16 : 831 - 840
  • [5] Protein Alpha Shape Similarity Analysis (PASSA): A new method for mapping protein binding sites. Application in the design of a selective inhibitor of Tyrosine kinase 2
    Tondel, K
    Anderssen, E
    Drablos, F
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (11) : 831 - 840
  • [6] Structural Analysis of ARC-Type Inhibitor (ARC-1034) Binding to Protein Kinase A Catalytic Subunit and Rational Design of Bisubstrate Analogue Inhibitors of Basophilic Protein Kinases
    Lavogina, Darja
    Lust, Marje
    Viil, Indrek
    Koenig, Norbert
    Raidaru, Gerda
    Rogozina, Jevgenia
    Enkvist, Erki
    Uri, Asko
    Bossemeyer, Dirk
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) : 308 - 321